Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 49, Issue 4, 2009, Pages 426-428

  Huang, Alice ^a   Quinn, Michael ^a   Tan, Jeffrey ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

Cervical cytology; Endocervical component; Previous high grade dysplasia; Uterine cervical dysplasia

Indexed keywords

ARTICLE; AUSTRALIA; DATA BASE; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; UTERINE ENDOCERVIX;

AUSTRALIA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CYTOLOGICAL TECHNIQUES; EVALUATION STUDIES AS TOPIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; REGISTRIES; RISK FACTORS; TIME FACTORS; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 70350137231     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2009.01014.x     Document Type: Article

References (11)

1. Australian government national health and research medical council (NHMRC). Screening to Prevent Cervical Cancer: Guidelines for the Management of Asymptomatic Women with Screen Detected Abnormalities, 2005. Canberra, ACT: NHMRC.
2. Australian Government Department of Health and Ageing. 2008. Cancer screening. Facts and key statistics: Detailed figures on cervical cancer and cervical cancer screening in Australia. Last updated http://www.cancerscreening. gov.au/internet/screening/publishing.nsf/Content/facts.
3. Martin-Hirch P, Lilford R, Jarvis G et al. Efficacy of cervicalsmear collection devices: A systemic review and meta-analysis. Lancet 1999; 354: 1763-1769.
4. Mitchell HS. Longitudinal analysis of histologic high grade disease after negative cervical cytology according to endocervical status. Cancer 2001; 93: 237-240.
5. Siebers AG, de Leeuw H, Verbeek AL et al. Prevalence of squamous abnormalities in women with a recent smear without endocervical cells is lower as compared to women with smears with endocervical cells. Cytopathology 2003; 14: 58-65.
6. Sidawy MK, Tabbara SO, Silveberg SG. Should we report cervical smears lacking endocervical component as unsatisfactory? Diagn Cytopathol 1992; 8: 567-570.
7. Mitchell HS. Longitudinal analysis of histologic high grade disease after negative cervical cytology according to endocervical status. Cancer Cytopathol 2001; 93: 237-240.
8. Selvaggi SM, Guidos BJ. Endocervical component: Is it a determinant of specimen adequacy? Diagn Cytopathol 2002; 26: 53-55.
9. Australian Government National Health and Research Medical Council (NHMRC). When does quality assurance in health care require independent ethical review? Endorsed February 2003. Canberra, ACT: NHMRC.
10. Dunn T, Landry E, Ring C, Martin C. Absent endocervical cells on pap smears after loop electrosurgical excision procedure. J Low Genit Tract Dis 2007; 11: 138-140.
11. Solomon D, Davey D, Kurman R et al. The Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002; 287: 2116.